News

Institute launches a new AI initiative to power biological research

Rachel Scanza
By Rachel Scanza
Dec. 14, 2024

With artificial intelligence (AI) poised to greatly accelerate the pace for novel discoveries in foundational biological research, the Stowers Institute launched the Office of Scientific Leadership AI Initiative, a new program designed to advance capabilities in machine learning and AI for addressing critical biological questions. Investigator Julia Zeitlinger, Ph.D., has been appointed to lead this effort and leverage cutting-edge computational techniques to accelerate scientific discoveries and drive innovation in biological research.

From left to right: Julia Zeitlinger, Ph.D., Jay Unruh, Ph.D., and Evelyn Travnik
From left to right: Julia Zeitlinger, Ph.D., Jay Unruh, Ph.D., and Evelyn Travnik

Zeitlinger will work to develop and execute a long-term strategy to build world-class AI-powered computational expertise. She will head the steering committee that, together with Chief Information Officer Evelyn Travnik and Director of Scientific Data Jay Unruh, Ph.D., prioritizes and implements computational efforts across the organization. She also advises the Stowers Fellows program and the Graduate School to attract, support, and maintain computational talent at the Institute.

“Biology is incredibly complex, and AI is an excellent way to detect the underlying patterns and rules. A great example is the information encoded in our DNA, how it us used to create gene products like proteins, and how those gene products function to support life,” said Zeitlinger. “I am passionate about leading the Institute’s new initiative to promote AI in our scientific research. It is both an exciting challenge and a huge opportunity.”

A fundamental biological quest is to understand how variations within our genetic code and the molecules arising from it not only make us unique but can also underlie disease or disease susceptibility. AI’s predictive capabilities can guide targeted experimental approaches to identify how these variations impact gene regulation and protein function, key factors governing development, health, and disease.

“Many of our investigators including Zeitlinger and our Technology Center scientists are engaged in the pursuit of understanding how sequences within our DNA genetic blueprint control gene activity and how the shape of proteins affects their function,” said Stowers Scientific Director Kausik Si, Ph.D.

“Leveraging the power of AI will enable researchers Institute-wide to answer questions that remain some of the biggest biological mysteries for the benefit of all,” said Stowers President and Chief Scientific Officer Alejandro Sánchez Alvarado, Ph.D.

This article is republished from Stowers News. Read the original here.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Rachel Scanza
Rachel Scanza

Rachel Scanza is a senior science writer at the Stowers Institute for Medical Research, where she translates complex science for a broad audience to author press releases, news stories, and features. Scanza earned a Ph.D. in atmospheric science from Cornell University and continued to investigate atmospheric aerosols on climate as a postdoctoral fellow at Pacific Northwest National Laboratory.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Protein modifications drive lung cancer resistance
Journal News

Protein modifications drive lung cancer resistance

Nov. 6, 2025

New assay enriches protein modifications in a single process, enabling detection of key changes in drug-resistant lung cancer cells that may guide future therapies.

How antigen-processing proteins shape immunity
Journal News

How antigen-processing proteins shape immunity

Nov. 6, 2025

Researchers show how components of the antigen processing machinery shape the immunopeptidome, offering insights into immune regulation and cancer biology.

New chemical strategy boosts accuracy in proteomics
Journal News

New chemical strategy boosts accuracy in proteomics

Nov. 6, 2025

Researchers develop a methylamine-based method that nearly eliminates peptide overlabeling in proteomics, improving accuracy in protein identification and quantitation.

Understanding the roles of extracellular matrix and vesicles in valvular disease
Profile

Understanding the roles of extracellular matrix and vesicles in valvular disease

Oct. 30, 2025

MOSAIC scholar Cassandra Clift uses mass spectrometry and multiomics to study cardiovascular calcification and collagen dysregulation, bridging her background in bioengineering and biology to investigate extracellular vesicles and heart disease.

Lipid profiles reveal sex differences in type 2 diabetes
Journal News

Lipid profiles reveal sex differences in type 2 diabetes

Oct. 29, 2025

Researchers explored the lipid profiles of individuals with type 2 diabetes and identified potentially useful lipid biomarkers for this condition.

Serum lipids may predict early diabetes risk
Journal News

Serum lipids may predict early diabetes risk

Oct. 29, 2025

Researchers found that levels of two key fatty acids may predict worsening tolerance for glucose, independent of body fat and insulin levels. In turn, these fatty acids may serve as early T2D biomarkers.